Search

Search Constraints

You searched for: Author/Creator Durham, S. R.

Search Results

1. A randomized, double‐blind, placebo‐controlled, dose‐finding trial with Lolium perenne peptide immunotherapy. Issue 4 (22nd December 2017)

3. Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration project. Issue 1 (23rd November 2016)

4. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Issue 1 (30th December 2016)

5. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Issue 8 (6th April 2017)

6. BSACI guideline for the diagnosis and management of allergic and non‐allergic rhinitis (Revised Edition 2017; First edition 2007). Issue 7 (7th July 2017)

7. BSACI guideline for the diagnosis and management of allergic and non‐allergic rhinitis (Revised Edition 2017; First edition 2007). Issue 7 (July 2017)

8. Clinical relevance is associated with allergen‐specific wheal size in skin prick testing. Issue 3 (March 2014)

9. Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen‐induced rhinoconjunctivitis – an EAACI position paper. Issue 5 (27th January 2017)